1255 — TATA Health International Holdings Income Statement
0.000.00%
Last trade - 00:00
Consumer CyclicalsHighly SpeculativeMicro Cap
- HK$72.85m
- HK$97.81m
- HK$144.61m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 358 | 342 | 155 | 161 | 145 |
Cost of Revenue | |||||
Gross Profit | 221 | 199 | 34.3 | 105 | 114 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 350 | 406 | 325 | 227 | 138 |
Operating Profit | 8.23 | -64.6 | -170 | -65.8 | 7 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 6.58 | -67.4 | -173 | -69.1 | 4.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 6.08 | -66.9 | -173 | -70.5 | 3.21 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -1.75 | -60.9 | -152 | -60.8 | 9.61 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.75 | -60.9 | -152 | -60.8 | 9.61 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.031 | -0.192 | -0.641 | -0.251 | -0.059 |